MOMO'S BREAKOUT BOARD

[dirkv]

APREA THERAPEUTICS INC APRE: 0,4799 +18,00%
52w: 0.3310 - 4.7

https://ir.aprea.com/static-files/30f4a16e-335b-4fa5-83d1-592b0aade43f

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing and commercializing novel cancer therapeutics that reactivate mutant protein 53 (p53) tumor suppressor protein. The Company's lead product candidate, APR-246, or eprenetapopt, is a small molecule p53 reactivator that is in clinical development for hematologic malignancies, including myelodysplastic syndromes, or myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). The Company's APR-548 is a second generation p53 reactivator that is a unique analog of eprenetapopt and therefore a pro-drug of MQ. APR-548 exhibits high oral bioavailability in preclinical testing and is being developed in an oral dosage form. The Company has initiated a Phase I clinical trial testing APR-548 in relapsed/refractory MDS and AML. Its solid tumor program includes its clinical trial evaluating eprenetapopt with anti-PD-1 therapy in advanced solid tumors.

Total Cash (mrq) 33.11M
Total Cash Per Share (mrq) 0.62
Total Debt (mrq) 110.55k
Shares Outstanding 53M
% Held by Insiders 1 24.17%